Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | ABL1 |
Variant | A344P |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | ABL1 A344P (corresponds to A363P in isoform IB) lies within the protein kinase domain of the Abl1 protein (UniProt.org). A344P is associated with resistance to some Abl1 inhibitors (PMID: 31543464), and results in increased Abl1 phosphorylation and transformation activity when expressed in the Abl1 1B splice isoform (PMID: 27890928), and therefore, is predicted to lead to a gain of Abl1 protein function. |
Associated Drug Resistance | Y |
Category Variants Paths |
ABL1 mutant ABL1 act mut ABL1 A344P |
Transcript | NM_005157.6 |
gDNA | chr9:g.130872982G>C |
cDNA | c.1030G>C |
Protein | p.A344P |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_005157.6 | chr9:g.130872982G>C | c.1030G>C | p.A344P | RefSeq | GRCh38/hg38 |
NM_005157 | chr9:g.130872982G>C | c.1030G>C | p.A344P | RefSeq | GRCh38/hg38 |
NM_005157.5 | chr9:g.130872982G>C | c.1030G>C | p.A344P | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|